Pimentel JM, Bosompra O, Trejo J. The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK-p65 NF-kappaB signaling
and inflammatory cytokine production to suppress triple-negative breast cancer
progression. J Biol Chem 2026 Jul 16:113341. doi: 10.1016/j.jbc.2026.113341.
PMID: 42463046
|